Synopsys (NASDAQ:SNPS) Shares Down 5.4% on Insider Selling

Key Points

• Synopsys shares fell about 5.4% to roughly $416 after Executive Chair Aart de Geus sold 25,000 shares for approximately $11.1 million. The sale occurred under a pre-arranged Rule 10b5-1 plan, reducing his direct holdings by 17.19%.
• Recent quarterly results were stronger than expected, with revenue up 42.4% year over year to $2.48 billion and EPS of $3.91 surpassing estimates by $0.24.
• Analysts remain broadly positive, with a “Moderate Buy” consensus and an average price target of $561.28, implying significant upside from the current price; however, higher bond yields have pressured semiconductor and high-valuation growth stocks.

Shares of Synopsys, Inc. (NASDAQ:SNPS - Get Free Report) traded down 5.4% during trading on Tuesday following insider selling activity. The stock traded as low as $421.17 and last traded at $416.0560. 347,224 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 1,987,778 shares. The stock had previously closed at $439.59.

Specifically, insider Geus Aart De sold 25,000 shares of the stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $445.55, for a total value of $11,138,750.00. Following the completion of the sale, the insider directly owned 120,421 shares of the company's stock, valued at approximately $53,653,576.55. This represents a 17.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Analyst Upgrades and Downgrades

SNPS has been the topic of a number of recent analyst reports. Bank of America raised their price target on Synopsys from $515.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. BNP Paribas Exane increased their target price on Synopsys from $425.00 to $450.00 and gave the stock an "underperform" rating in a research report on Thursday, May 28th. Berenberg Bank set a $633.00 price target on Synopsys in a report on Wednesday, May 27th. Citigroup upped their price target on Synopsys from $600.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Finally, Weiss Ratings raised shares of Synopsys from a "hold (c-)" rating to a "hold (c)" rating in a report on Thursday. Twelve investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and a consensus price target of $561.28.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts remain optimistic about Synopsys, with the consensus price target implying approximately 25.4% upside. Zacks noted that broad agreement among analysts raising earnings estimates may be a more useful bullish signal than the target price alone. Wall Street Analysts See a 25.39% Upside in Synopsys
• Positive Sentiment: Synopsys’ recent earnings momentum continues to support the bullish case: quarterly revenue rose 42.4% year over year to $2.48 billion, exceeding estimates, while EPS of $3.91 beat consensus by $0.24. Commentary also highlighted the company’s strong growth relative to its closest electronic design automation rival and potentially lower valuation multiple. The Market May Be Underestimating This AI Chip-Design Stock
• Positive Sentiment: Wall Street’s overall stance remains favorable. Synopsys has a “Moderate Buy” consensus rating, an average price target of $561.28, and recent support from Needham, Rosenblatt Securities and Robert W. Baird, which upgraded the stock to “outperform.” Is It Worth Investing in Synopsys Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Executive Chair Aart de Geus sold 25,000 shares for approximately $11.1 million, reducing his position by 17.19%. Because the transaction was conducted under a pre-arranged Rule 10b5-1 plan, it may be less indicative of changing confidence in the company, although insider selling can still weigh on sentiment. Synopsys Insider Geus Aart De Sells 25,000 Shares
• Negative Sentiment: Semiconductor stocks broadly declined at the open as a global bond selloff pushed long-term yields higher. Rising yields can pressure high-multiple growth stocks such as Synopsys, which trades at an elevated earnings multiple. Semiconductor Stocks Slide as Global Bond Selloff Lifts Yields

Synopsys Stock Down 5.1%

The company's 50 day moving average is $416.14 and its 200 day moving average is $440.15. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a market cap of $79.95 billion, a PE ratio of 73.55, a P/E/G ratio of 2.42 and a beta of 1.23.

Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company had revenue of $2.48 billion for the quarter, compared to analysts' expectations of $2.44 billion. During the same quarter in the prior year, the firm earned $3.39 earnings per share. Synopsys's revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, analysts predict that Synopsys, Inc. will post 11.03 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Synopsys

A number of hedge funds and other institutional investors have recently modified their holdings of SNPS. Foronjy Financial LLC boosted its position in Synopsys by 5.2% during the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company's stock valued at $210,000 after purchasing an additional 22 shares in the last quarter. AGH Wealth Advisors LLC lifted its position in Synopsys by 4.4% during the first quarter. AGH Wealth Advisors LLC now owns 569 shares of the semiconductor company's stock valued at $226,000 after acquiring an additional 24 shares during the last quarter. Hardy Reed LLC lifted its position in Synopsys by 0.8% during the fourth quarter. Hardy Reed LLC now owns 3,309 shares of the semiconductor company's stock valued at $1,554,000 after acquiring an additional 25 shares during the last quarter. Annis Gardner Whiting Capital Advisors LLC boosted its stake in Synopsys by 16.9% in the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 180 shares of the semiconductor company's stock valued at $85,000 after acquiring an additional 26 shares in the last quarter. Finally, MCF Advisors LLC boosted its stake in Synopsys by 17.8% in the fourth quarter. MCF Advisors LLC now owns 172 shares of the semiconductor company's stock valued at $81,000 after acquiring an additional 26 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source